Merck
MRK
#47
Rank
A$463.56 B
Marketcap
A$187.69
Share price
0.45%
Change (1 day)
46.58%
Change (1 year)

EPS for Merck (MRK)

EPS in 2026 (TTM): A$5.51

According to Merck's latest financial reports the company's current EPS (TTM) is A$5.12. In 2025 the company made an earnings per share (EPS) of A$10.47 an increase over its 2024 EPS that were of A$9.68.

EPS history for Merck from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$5.51-47.33%
2025A$10.478.15%
2024A$9.684308.46%
2023A$0.22-97.32%
2022A$8.2110.92%
2021A$7.4084.68%
2020A$4.01-27.2%
2019A$5.5063.44%
2018A$3.37151.11%
2017A$1.34-54.58%
2016A$2.9530.21%
2015A$2.27-61.99%
2014A$5.96180.51%
2013A$2.13-31.82%
2012A$3.126.62%
2011A$2.92

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$12.51 144.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$10.05 96.37%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$1.88-63.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$5.17 0.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$40.42 689.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$20.74 305.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$3.67-28.40%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
A$5.10-0.42%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$5.57 8.71%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
A$1.96-61.68%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel